🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and side effects of d...
Status
Unknown
Location
Hematology-Oncology & SCT Research Center
Start Date
2009-09
Trial ID
NCT01238328
Treatments Being Tested
This study proposes the use of a reduced intensity chemotherapy/radiation t...
Status
Completed
Location
Columbia University Medical Center
Start Date
2002-09
Trial ID
NCT01019876
An open, multi-center, randomized trial comparing haploidentical HSCTs from...
Status
Active Not Recruiting
Location
Xiangya Hospital Central South University
Start Date
2020-09-01
Trial ID
NCT04547049
This is a single-institution, phase II study to determine the event-free su...
Status
Completed
Location
University of Minnesota Masonic Cancer Center and Medical Center
Start Date
2016-03
Trial ID
NCT02582775
This study will gather information about the combination the drugs plerixaf...
Status
Completed
Location
Washington University School of Medicine
Start Date
2011-04-01
Trial ID
NCT01158118
Treatments Being Tested
The purpose of this study is to determine the safety and toxicity and feasi...
Status
Terminated
Location
Columbia Presbyterian Medical Center
Start Date
2007-09-06
Trial ID
NCT00801931
The purpose of this study is to determine if Bortezomib, known commercially...
Status
Completed
Location
Spectrum Health
Start Date
2012-04
Trial ID
NCT01860170
This phase II trial is studying how well rituximab works in preventing acut...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2009-12-10
Trial ID
NCT01044745
Treatments Being Tested
This is a phase II, open-label, prospective study of T cell receptor alpha/...
Status
Recruiting
Location
University of Minnesota Masonic Cancer Center
Start Date
2023-05-11
Trial ID
NCT05735717
The haplotype HSCT system including Bu(0.8mg/kg Q6hx2d)CTX(50mg/kgx4d)rATG(...
Status
Unknown
Location
Peking University Institute of Hematology,People's hospital Peking University
Start Date
2018-12-17
Trial ID
NCT03821987
Treatments Being Tested